Search results
Results from the Health.Zone Content Network
Feb. 6, 2024 -- People who alternated arms when receiving multiple shots of the COVID-19 vaccine saw an improved immunity response, according to new research. The research was published in The ...
A handful of reports have found that a small percentage of people develop tinnitus soon after getting vaccinated against COVID-19. Luis Alvarez/Getty Images. Experts are investigating if the COVID ...
How mRNA vaccines work. After being injected into the muscle of the upper arm, the mRNA, which is protected by a layer of lipids (fats), enters nearby cells. Inside the cell, the mRNA sheds its ...
The COVID-19 vaccine is safe for people with heart conditions.. Clinical trials have been done to determine the safety and effectiveness of each of the vaccines in use in the United States. These ...
March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus. In its announcement, the agency explained that the new ...
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7] [8]
The incidence of self-reported reactions — such as fever or fatigue — was 27.4% in people who only got the COVID vaccine, 27.6% in people who got both shots, and 12.7% for people who only got ...
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries.